Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic Stroke

NSI‐566 is a stable, primary adherent neural stem cell line derived from a single human fetal spinal cord and expanded epigenetically with no genetic modification. This cell line is being tested in clinical trials in the U.S. for treatment of amyotrophic lateral sclerosis and spinal cord injury. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guangzhu, Li, Ying, Reuss, James L., Liu, Nan, Wu, Cuiying, Li, Jingpo, Xu, Shuangshuang, Wang, Feng, Hazel, Thomas G., Cunningham, Miles, Zhang, Hongtian, Dai, Yiwu, Hong, Peng, Zhang, Ping, He, Jianghong, Feng, Huiru, Lu, Xiangdong, Ulmer, John L., Johe, Karl K., Xu, Ruxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766600/
https://www.ncbi.nlm.nih.gov/pubmed/31241246
http://dx.doi.org/10.1002/sctm.18-0220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766600/
https://www.ncbi.nlm.nih.gov/pubmed/31241246
http://dx.doi.org/10.1002/sctm.18-0220

Ejemplares similares